Experience

• • Achieved complete victory for pharmaceutical clients at trial and on appeal in a Hatch-Waxman case involving multiple generic challenges to patents covering a blockbuster drug.
  • Participated a jury trial resulting in a $539 million damages award for a technology client.
  • Represent pharmaceutical company in defending against a challenge to patents covering a blockbuster oncology drug.
  • Represent biotechnology company in multiple appeals concerning patents relating to vaccine formulation.
  • Secured a victory for a pharmaceutical company in a jury trial on patent validity and obtained a $2.15 billion settlement for patent infringement damages resulting from an “at-risk” launch of a generic pharmaceutical product. 
  • Represented a biotechnology company in a highly successful five-year legal battle involving a licensing dispute with a major clinical diagnostics company. The 10-week jury trial resulted in a $505 million verdict for our client and ultimately led to a $1.4 billion acquisition of our client by the defendant. 
  • Represented a major pharmaceutical company in multiple jury trials, bench trials, and US and international arbitrations involving biotechnology patents. 
  • Achieved a favorable jury verdict for a medical device company in patent litigation concerning safety needles and blood collection devices.
  • Successfully argued on behalf of a pharmaceutical company for dismissal of patent infringement allegations concerning a biotechnology patent on the grounds that the asserted claims were unpatentable. 
  • Served as lead counsel for a power wheelchair manufacturer in defending against patent infringement allegations. 
  • Represented a medical device company in defending a patent infringement case involving surgical ablation devices. 
  • Successfully argued in the Federal Circuit for dismissal of the appeal of an inter partes reexam in which the patent claims asserted against a medical device manufacturer were found invalid. 
  • Represented a pharmaceutical company in the appeals of Hatch-Waxman cases involving treatments for Hepatitis C and HIV. 
  • Successfully represented a pharmaceutical company in a Hatch-Waxman patent infringement case involving a treatment for HIV. 
  • Served as lead counsel for in a patent infringement case involving biotechnology. 
  • Served as lead counsel for the defendant in a patent infringement case concerning digital audio technology. 
  • Represented a pharmaceutical company in a license dispute concerning drug-eluting stents.
  • Successfully represented a pharmaceutical company in a Hatch-Waxman patent infringement case involving a treatment for Parkinson's disease.